- cafead Oct 03, 2023 at 10:12: AM
via Amicus Therapeutics announced Tuesday that it has entered into a definitive agreement with Blackstone for a $430 million financing collaboration.
As part of the agreement, Blackstone is providing the biotech with a $400 million senior secured term loan facility as well as a $30 million investment in Amicus common stock.
article source
As part of the agreement, Blackstone is providing the biotech with a $400 million senior secured term loan facility as well as a $30 million investment in Amicus common stock.
article source